The role of the alternative coreceptor GPR15 in SIV tropism for human cells

Virology

Volumn 433, Issue 1, 2012, Pages 73-84

  Kiene, Miriam ^a,b   Marzi, Andrea ^c,h   Urbanczyk, Andreas ^c   Bertram, Stephanie ^d   Fisch, Tanja ^c,i   Nehlmeier, Inga ^d   Gnirß, Kerstin ^d   Karsten, Christina B ^a,d   Palesch, David ^e   Münch, Jan ^e   Chiodi, Francesca ^b   Pöhlmann, Stefan ^a,c,d   Steffen, Imke ^a,f,g  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d GERMAN PRIMATE CENTER   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ Amgen Research GmbH   (Germany)

Author keywords

Coreceptor; CXCR6; Entry; GPR15; SIV

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 15; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; B LYMPHOCYTE; CCR5 GENE; CD19+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; EMBRYO; GENE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRAL TROPISM; VIRUS ISOLATION;

ANTIGENS, CD; B-LYMPHOCYTES; CELL LINE; HUMANS; RECEPTORS, CCR5; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECEPTORS, VIRUS; RNA, SMALL INTERFERING; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TRANSFECTION; VIRAL TROPISM; VIRUS INTERNALIZATION; VIRUS REPLICATION;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84866172017     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.07.012     Document Type: Article

References (91)

1. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
2. Blaak H., Boers P.H., Gruters R.A., Schuitemaker H., van der Ende M.E., Osterhaus A.D. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J. Virol. 2005, 79:1686-1700.
3. Chaipan C., Steffen I., Tsegaye T.S., Bertram S., Glowacka I., Kato Y., Schmokel J., Munch J., Simmons G., Gerardy-Schahn R., Pöhlmann S. Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2. Retrovirology 2010, 7:47.
4. Chen Z., Kwon D., Jin Z., Monard S., Telfer P., Jones M.S., Lu C.Y., Aguilar R.F., Ho D.D., Marx P.A. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J. Exp. Med. 1998, 188:2057-2065.
5. Chen Z., Zhou P., Ho D.D., Landau N.R., Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 1997, 71:2705-2714.
6. Choe H., Farzan M., Konkel M., Martin K., Sun Y., Marcon L., Cayabyab M., Berman M., Dorf M.E., Gerard N., Gerard C., Sodroski J. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J. Virol. 1998, 72:6113-6118.
7. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
8. Chung J.J., Okamoto Y., Coblitz B., Li M., Qiu Y., Shikano S. PI3K/Akt signalling-mediated protein surface expression sensed by 14-3-3 interacting motif. FEBS J. 2009, 276:5547-5558.
9. Cilliers T., Willey S., Sullivan W.M., Patience T., Pugach P., Coetzer M., Papathanasopoulos M., Moore J.P., Trkola A., Clapham P., Morris L. Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology 2005, 339:136-144.
10. Clavel F., Mansinho K., Chamaret S., Guetard D., Favier V., Nina J., Santos-Ferreira M.O., Champalimaud J.L., Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N. Engl. J. Med. 1987, 316:1180-1185.
11. Clayton F., Kotler D.P., Kuwada S.K., Morgan T., Stepan C., Kuang J., Le J., Fantini J. Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am. J. Pathol. 2001, 159:1933-1939.
12. Cohen M.S., Hellmann N., Levy J.A., DeCock K., Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest 2008, 118:1244-1254.
13. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206:935-944.
14. de Silva T.I., Cotten M., Rowland-Jones S.L. HIV-2: the forgotten AIDS virus. Trends Microbiol. 2008, 16:588-595.
15. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273:1856-1862.
16. Del Prete G.Q., Haggarty B., Leslie G.J., Jordan A.P., Romano J., Wang N., Wang J., Holmes M.C., Montefiori D.C., Hoxie J.A. Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4. J.Virol. 2009, 83:9911-9922.
17. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
18. Deng H.K., Unutmaz D., Kewalramani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
19. Doranz B.J., Rucker J., Yi Y., Smyth R.J., Samson M., Peiper S.C., Parmentier M., Collman R.G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
20. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
21. Dumonceaux J., Nisole S., Chanel C., Quivet L., Amara A., Baleux F., Briand P., Hazan U. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J. Virol. 1998, 72:512-519.
22. Edinger A.L., Amedee A., Miller K., Doranz B.J., Endres M., Sharron M., Samson M., Lu Z.H., Clements J.E., Murphey-Corb M., Peiper S.C., Parmentier M., Broder C.C., Doms R.W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. U.S.A 1997, 94:4005-4010.
23. Edinger A.L., Hoffman T.L., Sharron M., Lee B., O'Dowd B., Doms R.W. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998, 249:367-378.
24. Edinger A.L., Hoffman T.L., Sharron M., Lee B., Yi Y., Choe W., Kolson D.L., Mitrovic B., Zhou Y., Faulds D., Collman R.G., Hesselgesser J., Horuk R., Doms R.W. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 1998, 72:7934-7940.
25. Edinger A.L., Mankowski J.L., Doranz B.J., Margulies B.J., Lee B., Rucker J., Sharron M., Hoffman T.L., Berson J.F., Zink M.C., Hirsch V.M., Clements J.E., Doms R.W. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. U.S.A 1997, 94:14742-14747.
26. Elbim C., Monceaux V., Mueller Y.M., Lewis M.G., Francois S., Diop O., Akarid K., Hurtrel B., Gougerot-Pocidalo M.A., Levy Y., Katsikis P.D., Estaquier J. Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J. Immunol. 2008, 181:8613-8623.
27. Elliott S.T., Riddick N.E., Francella N., Paiardini M., Vanderford T.H., Li B., Apetrei C., Sodora D.L., Derdeyn C.A., Silvestri G., Collman R.G. Cloning and analysis of sooty mangabey alternative coreceptors that support simian immunodeficiency virus SIVsmm entry independently of CCR5. J. Virol. 2012, 86:898-908.
28. Endres M.J., Clapham P.R., Marsh M., Ahuja M., Turner J.D., McKnight A., Thomas J.F., Stoebenau-Haggarty B., Choe S., Vance P.J., Wells T.N., Power C.A., Sutterwala S.S., Doms R.W., Landau N.R., Hoxie J.A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996, 87:745-756.
29. Farzan M., Choe H., Martin K., Marcon L., Hofmann W., Karlsson G., Sun Y., Barrett P., Marchand N., Sullivan N., Gerard N., Gerard C., Sodroski J. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 1997, 186:405-411.
30. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
31. Forte S., Harmon M.E., Pineda M.J., Overbaugh J. Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5. J. Virol. 2003, 77:9723-9727.
32. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kaplan M., Haynes B.F., Palker T.J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
33. Gondois-Rey F., Grivel J.C., Biancotto A., Pion M., Vigne R., Margolis L.B., Hirsch I. Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue. AIDS 2002, 16:1245-1249.
34. Grivel J.C., Penn M.L., Eckstein D.A., Schramm B., Speck R.F., Abbey N.W., Herndier B., Margolis L., Goldsmith M.A. Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J. Virol. 2000, 74:5347-5351.
35. Haim H., Strack B., Kassa A., Madani N., Wang L., Courter J.R., Princiotto A., McGee K., Pacheco B., Seaman M.S., Smith A.B., Sodroski J. Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. PLoS. Pathog. 2011, 7:e1002101.
36. Harrison S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008, 15:690-698.
37. Hill C.M., Deng H., Unutmaz D., Kewalramani V.N., Bastiani L., Gorny M.K., Zolla-Pazner S., Littman D.R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 1997, 71:6296-6304.
38. Hoffman T.L., LaBranche C.C., Zhang W., Canziani G., Robinson J., Chaiken I., Hoxie J.A., Doms R.W. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc. Natl. Acad. Sci. U.S.A 1999, 96:6359-6364.
39. Hsu M., Harouse J.M., Gettie A., Buckner C., Blanchard J., Cheng-Mayer C. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. J. Virol. 2003, 77:989-998.
40. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 1996, 2:1240-1243.
41. Jiang C., Parrish N.F., Wilen C.B., Li H., Chen Y., Pavlicek J.W., Berg A., Lu X., Song H., Tilton J.C., Pfaff J.M., Henning E.A., Decker J.M., Moody M.A., Drinker M.S., Schutte R., Freel S., Tomaras G.D., Nedellec R., Mosier D.E., Haynes B.F., Shaw G.M., Hahn B.H., Doms R.W., Gao F. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J. Virol. 2011, 85:10669-10681.
42. Kanbe K., Shimizu N., Soda Y., Takagishi K., Hoshino H. A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immunodeficiency virus type 2. Virology 1999, 265:264-273.
43. Kantarci O.H., Morales Y., Ziemer P.A., Hebrink D.D., Mahad D.J., Atkinson E.J., Achenbach S.J., De Andrade M., Mack M., Ransohoff R.M., Lassmann H., Bruck W., Weinshenker B.G., Lucchinetti C.F. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J. Neuroimmunol. 2005, 169:137-143.
44. Keele B.F., Jones J.H., Terio K.A., Estes J.D., Rudicell R.S., Wilson M.L., Li Y., Learn G.H., Beasley T.M., Schumacher-Stankey J., Wroblewski E., Mosser A., Raphael J., Kamenya S., Lonsdorf E.V., Travis D.A., Mlengeya T., Kinsel M.J., Else J.G., Silvestri G., Goodall J., Sharp P.M., Shaw G.M., Pusey A.E., Hahn B.H. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009, 460:515-519.
45. Kirchhoff F., Pöhlmann S., Hamacher M., Means R.E., Kraus T., Uberla K., Di Marzio P. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 1997, 71:6509-6516.
46. Kolchinsky P., Mirzabekov T., Farzan M., Kiprilov E., Cayabyab M., Mooney L.J., Choe H., Sodroski J. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication. J. Virol. 1999, 73:8120-8126.
47. Laguette N., Rahm N., Sobhian B., Chable-Bessia C., Munch J., Snoeck J., Sauter D., Switzer W.M., Heneine W., Kirchhoff F., Delsuc F., Telenti A., Benkirane M. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host. Microbe 2012, 11:205-217.
48. Lee B., Leslie G., Soilleux E., O'Doherty U., Baik S., Levroney E., Flummerfelt K., Swiggard W., Coleman N., Malim M., Doms R.W. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 2001, 75:12028-12038.
49. Letvin N.L., Daniel M.D., Sehgal P.K., Desrosiers R.C., Hunt R.D., Waldron L.M., MacKey J.J., Schmidt D.K., Chalifoux L.V., King N.W. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985, 230:71-73.
50. Li Q., Estes J.D., Duan L., Jessurun J., Pambuccian S., Forster C., Wietgrefe S., Zupancic M., Schacker T., Reilly C., Carlis J.V., Haase A.T. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J. Infect. Dis. 2008, 197:420-429.
51. Lusso P. HIV and the chemokine system: 10 years later. EMBO J. 2006, 25:447-456.
52. Lusso P., Cocchi F., Balotta C., Markham P.D., Louie A., Farci P., Pal R., Gallo R.C., Reitz M.S. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 1995, 69:3712-3720.
53. Maresca M., Mahfoud R., Garmy N., Kotler D.P., Fantini J., Clayton F. The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. J. Biomed. Sci. 2003, 10:156-166.
54. Martin K.A., Wyatt R., Farzan M., Choe H., Marcon L., Desjardins E., Robinson J., Sodroski J., Gerard C., Gerard N.P. CD4-independent binding of SIV gp120 to rhesus CCR5. Science 1997, 278:1470-1473.
55. Marzi A., Mitchell D.A., Chaipan C., Fisch T., Doms R.W., Carrington M., Desrosiers R.C., Pöhlmann S. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin. Virology 2007, 368:322-330.
56. McKeating J.A., McKnight A., McIntosh K., Clapham P.R., Mulder C., Weiss R.A. Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J. Gen. Virol. 1989, 70(Pt 12):3327-3333.
57. McKnight A., Dittmar M.T., Moniz-Periera J., Ariyoshi K., Reeves J.D., Hibbitts S., Whitby D., Aarons E., Proudfoot A.E., Whittle H., Clapham P.R. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J. Virol. 1998, 72:4065-4071.
58. Means R.E., Greenough T., Desrosiers R.C. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J. Virol. 1997, 71:7895-7902.
59. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., Boden D., Racz P., Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200:761-770.
60. Mori K., Ringler D.J., Kodama T., Desrosiers R.C. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 1992, 66:2067-2075.
61. Morner A., Bjorndal A., Albert J., Kewalramani V.N., Littman D.R., Inoue R., Thorstensson R., Fenyo E.M., Bjorling E. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 1999, 73:2343-2349.
62. Neil S.J., Aasa-Chapman M.M., Clapham P.R., Nibbs R.J., McKnight A., Weiss R.A. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J. Virol. 2005, 79:9618-9624.
63. Nishimura Y., Igarashi T., Donau O.K., Buckler-White A., Buckler C., Lafont B.A., Goeken R.M., Goldstein S., Hirsch V.M., Martin M.A. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc. Natl. Acad. Sci. U.S.A 2004, 101:12324-12329.
64. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 2000, 74:10074-10080.
65. Papkalla A., Munch J., Otto C., Kirchhoff F. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J. Virol. 2002, 76:8455-8459.
66. Pöhlmann S., Krumbiegel M., Kirchhoff F. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. J. Gen. Virol 1999, 80(Pt 5):1241-1251.
67. Pöhlmann S., Lee B., Meister S., Krumbiegel M., Leslie G., Doms R.W., Kirchhoff F. Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry. J. Virol. 2000, 74:5075-5082.
68. Pöhlmann S., Leslie G.J., Edwards T.G., Macfarlan T., Reeves J.D., Hiebenthal-Millow K., Kirchhoff F., Baribaud F., Doms R.W. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 2001, 75:10523-10526.
69. Pöhlmann S., Munch J., Aziz S., Reeves J.D., Otto C., Leslie G.J., Hofmann H., Puffer B.A., Baribaud F., Marzi A., Gramberg T., Chen Z., Stolte N., Haaft P.T., Heeney J.L., Stahl-Hennig C., Matz-Rensing K., Schneider T., Doms R.W., Kirchhoff F. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo. Virology 2007, 360:275-285.
70. Pöhlmann S., Stolte N., Munch J., Ten Haaft P., Heeney J.L., Stahl-Hennig C., Kirchhoff F. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo. J. Infect. Dis. 1999, 180:1494-1502.
71. Reeves J.D., Hibbitts S., Simmons G., McKnight A., Azevedo-Pereira J.M., Moniz-Pereira J., Clapham P.R. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J. Virol. 1999, 73:7795-7804.
72. Rizzuto C.D., Wyatt R., Hernandez-Ramos N., Sun Y., Kwong P.D., Hendrickson W.A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280:1949-1953.
73. Rucker J., Edinger A.L., Sharron M., Samson M., Lee B., Berson J.F., Yi Y., Margulies B., Collman R.G., Doranz B.J., Parmentier M., Doms R.W. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 1997, 71:8999-9007.
74. Salter R.D., Howell D.N., Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985, 21:235-246.
75. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725.
76. Schols D., De Clercq E. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells. J. Gen. Virol 1998, 79(Pt 9):2203-2205.
77. Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Philos. Trans. R. Soc. Lon. B Biol. Sci. 2010, 365:2487-2494.
78. Sharron M., Pöhlmann S., Price K., Lolis E., Tsang M., Kirchhoff F., Doms R.W., Lee B. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood 2000, 96:41-49.
79. Shimizu N., Soda Y., Kanbe K., Liu H.Y., Jinno A., Kitamura T., Hoshino H. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J. Virol. 1999, 73:5231-5239.
80. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., Burke E., Buchmeier M.J., Soilleux E.J., Riley J.L., Doms R.W., Bates P., Pöhlmann S. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123.
81. Sol N., Ferchal F., Braun J., Pleskoff O., Treboute C., Ansart I., Alizon M. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J. Virol. 1997, 71:8237-8244.
82. Spina C.A., Prince H.E., Richman D.D. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest 1997, 99:1774-1785.
83. Steffen I., Pöhlmann S. Peptide-based inhibitors of the HIV envelope protein and other class I viral fusion proteins. Curr. Pharm. Des 2010, 16:1143-1158.
84. Steinberger P., Andris-Widhopf J., Buhler B., Torbett B.E., Barbas C.F. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc. Natl. Acad. Sci. U.S.A 2000, 97:805-810.
85. Tilton J.C., Doms R.W. Entry inhibitors in the treatment of HIV-1 infection. Antiviral Res. 2010, 85:91-100.
86. Veazey R.S., Mansfield K.G., Tham I.C., Carville A.C., Shvetz D.E., Forand A.E., Lackner A.A. Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection. J. Virol. 2000, 74:11001-11007.
87. Veazey R.S., Tham I.C., Mansfield K.G., DeMaria M., Forand A.E., Shvetz D.E., Chalifoux L.V., Sehgal P.K., Lackner A.A. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 2000, 74:57-64.
88. Wilen C.B., Wang J., Tilton J.C., Miller J.C., Kim K.A., Rebar E.J., Sherrill-Mix S.A., Patro S.C., Secreto A.J., Jordan A.P., Lee G., Kahn J., Aye P.P., Bunnell B.A., Lackner A.A., Hoxie J.A., Danet-Desnoyers G.A., Bushman F.D., Riley J.L., Gregory P.D., June C.H., Holmes M.C., Doms R.W. Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. PLoS. Pathog. 2011, 7:e1002020.
89. Willey S.J., Reeves J.D., Hudson R., Miyake K., Dejucq N., Schols D., De Clercq E., Bell J., McKnight A., Clapham P.R. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells. J. Virol. 2003, 77:6138-6152.
90. Zhang Y., Lou B., Lal R.B., Gettie A., Marx P.A., Moore J.P. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 2000, 74:6893-6910.
91. Zhang Y.J., Zhang L., Ketas T., Korber B.T., Moore J.P. HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry. AIDS Res. Hum. Retroviruses 2001, 17:217-227.